Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Kalamarides

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
La Revue Du Praticien|October 16, 2024
[Living with… neurofibromatosis type 2]Michel Kalamarides
Acta Neurochirurgica|January 8, 2020
Response to: "what is the advantage of using sodium fluorescein during resection of peripheral nerve tumors?"Matthieu Peyre, Michel Kalamarides
La Revue Du Praticien|February 24, 2007
[Meningiomas]Michel Kalamarides, Stéphane Goutagny
Journal of Neuro-Oncology|August 18, 2010
Meningiomas and neurofibromatosisStéphane Goutagny, Michel Kalamarides
The Lancet. Oncology|March 19, 2017
Epigenetics: a new tool for meningioma management?Marc Sanson, Michel Kalamarides
Neuro-Oncology|October 2, 2018
TERT, the target?Felix Sahm, Michel Kalamarides
World Neurosurgery|March 17, 2017
Dramatic Shrinkage with Reduced Vascularization of Large Meningiomas After Cessation of Progestin TreatmentMichel Kalamarides, Matthieu Peyre
The New England Journal of Medicine|March 30, 2022
Cellular Origin of Sporadic CCMs. ReplyMatthieu Peyre, Angeliki Louvi, Michel Kalamarides
Cancers|August 7, 2021
Mouse Models in Meningioma Research: A Systematic ReviewJulien Boetto, Matthieu Peyre, Michel Kalamarides
Current Opinion in Oncology|October 11, 2023
Schwannomatosis: a Realm Reborn: year oneMartin Planet, Michel Kalamarides, Matthieu Peyre
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
La Revue Du Praticien|October 16, 2024
[Living with… neurofibromatosis type 2]Michel Kalamarides
Acta Neurochirurgica|January 8, 2020
Response to: "what is the advantage of using sodium fluorescein during resection of peripheral nerve tumors?"Matthieu Peyre, Michel Kalamarides
La Revue Du Praticien|February 24, 2007
[Meningiomas]Michel Kalamarides, Stéphane Goutagny
Journal of Neuro-Oncology|August 18, 2010
Meningiomas and neurofibromatosisStéphane Goutagny, Michel Kalamarides
The Lancet. Oncology|March 19, 2017
Epigenetics: a new tool for meningioma management?Marc Sanson, Michel Kalamarides
Neuro-Oncology|October 2, 2018
TERT, the target?Felix Sahm, Michel Kalamarides
World Neurosurgery|March 17, 2017
Dramatic Shrinkage with Reduced Vascularization of Large Meningiomas After Cessation of Progestin TreatmentMichel Kalamarides, Matthieu Peyre
The New England Journal of Medicine|March 30, 2022
Cellular Origin of Sporadic CCMs. ReplyMatthieu Peyre, Angeliki Louvi, Michel Kalamarides
Cancers|August 7, 2021
Mouse Models in Meningioma Research: A Systematic ReviewJulien Boetto, Matthieu Peyre, Michel Kalamarides
Current Opinion in Oncology|October 11, 2023
Schwannomatosis: a Realm Reborn: year oneMartin Planet, Michel Kalamarides, Matthieu Peyre
Pageof 16